Breaking News Instant updates and real-time market news.

ADMA

ADMA Biologics

$4.53

0.11 (2.49%)

07:42
07/13/18
07/13
07:42
07/13/18
07:42

ADMA Biologics initiated with an Outperform at Oppenheimer

Oppenheimer analyst Leland Gershell initiated ADMA Biologics with an Outperform rating and $13 price target, telling investors in a research note that he sees ADMA as an early turnaround story that is set to outperform heading into catalysts in the second half of the year and beyond. Although shares are up ~40% YTD, Gershell believes the market has trailed the company's strengthening fundamentals due to a lack of regulatory visibility, providing an attractive opportunity for investors.

ADMA ADMA Biologics
$4.53

0.11 (2.49%)

11/14/17
RAJA
11/14/17
UPGRADE
RAJA
Outperform
ADMA Biologics upgraded to Outperform from Market Perform at Raymond James
11/14/17
11/14/17
UPGRADE
Target $5

Outperform
ADMA Biologics upgraded to Outperform at Raymond James
As previously reported, Raymond James upgraded ADMA Biologics to Outperform from Market Perform with a $5 price target. Analyst Reni Benjamin has increased confidence that RI-002 will be approved once manufacturing issues are resolved, said the Biotest acquisition should provide downside protection, and believes last week's equity raise removes an overhang.
06/07/18
06/07/18
NO CHANGE

ADMA Biologics files to sell common stock, no amount given
Raymond James & Associates, Inc. is acting as the sole book-running manager of the proposed offering.
06/13/18
LTCO
06/13/18
NO CHANGE
Target $7.5
LTCO
Buy
ADMA Biologics price target lowered to $7.50 from $10 at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter raised his price target for ADMA Biologics to $7.50 to reflect the recent financing and increasing risk of delay to timelines for completion of FDA inspection of the company's Boca Raton plasma fractionation facility. The analyst, however, reiterates a Buy rating on the shares. He continues to believe once the facility remediation is complete there is "significant commercial potential" for RI-002.

TODAY'S FREE FLY STORIES

ACRS

Aclaris Therapeutics

$20.49

-0.11 (-0.53%)

, LLY

Eli Lilly

$89.06

-0.64 (-0.71%)

07:45
07/17/18
07/17
07:45
07/17/18
07:45
Recommendations
Aclaris Therapeutics, Eli Lilly, Pfizer analyst commentary  »

Aclaris offers best…

ACRS

Aclaris Therapeutics

$20.49

-0.11 (-0.53%)

LLY

Eli Lilly

$89.06

-0.64 (-0.71%)

PFE

Pfizer

$37.39

-0.14 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 22

    Aug

  • 10

    Sep

NEWR

New Relic

$109.01

0.35 (0.32%)

07:39
07/17/18
07/17
07:39
07/17/18
07:39
Initiation
New Relic initiated  »

New Relic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:38
07/17/18
07/17
07:38
07/17/18
07:38
Hot Stocks
Goldman Sachs reports Q2 FICC revenue $1.68B, 45% higher than last year »

Net revenues in Fixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$36.92

3 (8.84%)

07:38
07/17/18
07/17
07:38
07/17/18
07:38
Technical Analysis
Technical Take: iQIYI falls, completes Skymoons acquisition »

The shares of iQIYI (IQ)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$35.60

2.5 (7.55%)

07:37
07/17/18
07/17
07:37
07/17/18
07:37
Hot Stocks
Novocure announces scientific track for tumor treating fields at EMBS »

Novocure announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

RVI

Retail Value

$35.60

-0.36 (-1.00%)

, DDR

DDR Corp.

$14.31

-0.045 (-0.31%)

07:36
07/17/18
07/17
07:36
07/17/18
07:36
Initiation
Retail Value, DDR Corp. initiated  »

Retail Value initiated…

RVI

Retail Value

$35.60

-0.36 (-1.00%)

DDR

DDR Corp.

$14.31

-0.045 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:36
07/17/18
07/17
07:36
07/17/18
07:36
Hot Stocks
Goldman Sachs reports Q2 annualized ROE 12.8% »

Annualized return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$2.64

-0.12 (-4.35%)

07:35
07/17/18
07/17
07:35
07/17/18
07:35
Hot Stocks
22nd Century comments on FDA's ANPRM to lessen nicotine in cigarettes »

22nd Century responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

, MSFT

Microsoft

$104.91

-0.51 (-0.48%)

07:35
07/17/18
07/17
07:35
07/17/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NFLX

Netflix

$400.24

4.32 (1.09%)

MSFT

Microsoft

$104.91

-0.51 (-0.48%)

SNAP

Snap

$13.07

-0.295 (-2.21%)

FOXA

21st Century Fox

$46.71

-0.84 (-1.77%)

MS

Morgan Stanley

$48.91

0.85 (1.77%)

TGT

Target

$77.20

-0.525 (-0.68%)

FSLR

First Solar

$53.99

-0.08 (-0.15%)

CZR

Caesars

$11.63

0.075 (0.65%)

FTI

TechnipFMC

$30.58

-0.36 (-1.16%)

HFC

HollyFrontier

$68.91

0.25 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 19

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 02

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

BCRX

BioCryst

$6.20

0.01 (0.16%)

07:34
07/17/18
07/17
07:34
07/17/18
07:34
Upgrade
BioCryst rating change  »

BioCryst upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:33
07/17/18
07/17
07:33
07/17/18
07:33
Earnings
Goldman Sachs reports Q2 EPS $5.98, consensus $4.66 »

Reports Q2 revenue $9.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

, LB

L Brands

$32.01

0.31 (0.98%)

07:32
07/17/18
07/17
07:32
07/17/18
07:32
Hot Stocks
Columbus signs renewal agreement with Victoria's Secret »

Alliance Data Systems…

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

LB

L Brands

$32.01

0.31 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

PRIM

Primoris

$28.12

-0.51 (-1.78%)

07:32
07/17/18
07/17
07:32
07/17/18
07:32
Hot Stocks
Primoris announces electrical distribution award valued over $75M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$41.10

1.38 (3.47%)

07:30
07/17/18
07/17
07:30
07/17/18
07:30
Recommendations
Zscaler analyst commentary  »

Zscaler price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$40.55

-4.34 (-9.67%)

, QEP

QEP Resources

$12.09

-0.67 (-5.25%)

07:30
07/17/18
07/17
07:30
07/17/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TSRO

Tesaro

$40.55

-4.34 (-9.67%)

QEP

QEP Resources

$12.09

-0.67 (-5.25%)

HUBG

Hub Group

$49.10

-1.85 (-3.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 19

    Aug

RPM

RPM

$60.00

-0.54 (-0.89%)

07:27
07/17/18
07/17
07:27
07/17/18
07:27
Downgrade
RPM rating change  »

RPM downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

OSUR

OraSure

$16.28

-1.04 (-6.00%)

07:27
07/17/18
07/17
07:27
07/17/18
07:27
Recommendations
OraSure analyst commentary  »

OraSure weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

NFLX

Netflix

$400.24

4.32 (1.09%)

07:26
07/17/18
07/17
07:26
07/17/18
07:26
Recommendations
Netflix analyst commentary  »

Canaccord views Netflix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOR

ElectroCore

$14.49

-0.51 (-3.40%)

07:25
07/17/18
07/17
07:25
07/17/18
07:25
Initiation
ElectroCore initiated  »

ElectroCore initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$30.58

-0.36 (-1.16%)

07:24
07/17/18
07/17
07:24
07/17/18
07:24
Initiation
TechnipFMC initiated  »

TechnipFMC assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

QTS

QTS Realty Trust

$40.90

-0.05 (-0.12%)

07:23
07/17/18
07/17
07:23
07/17/18
07:23
Initiation
QTS Realty Trust initiated  »

QTS Realty Trust resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BA

Boeing

$356.01

5.2 (1.48%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Hot Stocks
Boeing signs integrated services agreement with Blackshape »

Boeing announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Recommendations
Netflix analyst commentary  »

Oppenheimer remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$64.05

0.77 (1.22%)

07:21
07/17/18
07/17
07:21
07/17/18
07:21
Initiation
Interxion initiated  »

Interxion resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.